BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 28376589)

  • 21. PTEN loss and KRAS activation leads to the formation of serrated adenomas and metastatic carcinoma in the mouse intestine.
    Davies EJ; Marsh Durban V; Meniel V; Williams GT; Clarke AR
    J Pathol; 2014 May; 233(1):27-38. PubMed ID: 24293351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression of phosphatase of regeneration liver-3 in human colorectal carcinoma and its prognosis value].
    Zhao GP; Zhou ZG; Lei WZ; Wang C; Zheng XL; Zheng YC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Sep; 11(5):487-91. PubMed ID: 18803057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The metastasis suppressor, N-myc downregulated gene 1 (NDRG1), is a prognostic biomarker for human colorectal cancer.
    Mao Z; Sun J; Feng B; Ma J; Zang L; Dong F; Zhang D; Zheng M
    PLoS One; 2013; 8(7):e68206. PubMed ID: 23874544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of MMP-7 and PTEN expression in colorectal cancer.
    Bi Z; Dong LD; Gu XM
    Hepatogastroenterology; 2013; 60(121):32-6. PubMed ID: 22944341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinicopathological significance of REIC expression in colorectal carcinomas.
    Wang W; Zhu W; Xu XY; Nie XC; Yang X; Xing YN; Yu M; Liu YP; Takano Y; Zheng HC
    Histol Histopathol; 2012 Jun; 27(6):735-43. PubMed ID: 22473694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-myc downstream regulated gene-1/Cap43 may play an important role in malignant progression of prostate cancer, in its close association with E-cadherin.
    Song Y; Oda Y; Hori M; Kuroiwa K; Ono M; Hosoi F; Basaki Y; Tokunaga S; Kuwano M; Naito S; Tsuneyoshi M
    Hum Pathol; 2010 Feb; 41(2):214-22. PubMed ID: 19800102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of PTEN expression is associated with colorectal cancer liver metastasis and poor patient survival.
    Sawai H; Yasuda A; Ochi N; Ma J; Matsuo Y; Wakasugi T; Takahashi H; Funahashi H; Sato M; Takeyama H
    BMC Gastroenterol; 2008 Nov; 8():56. PubMed ID: 19036165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low expression of FHIT and PTEN correlates with malignancy of gastric carcinomas: tissue-array findings.
    Zheng H; Takahashi H; Murai Y; Cui Z; Nomoto K; Tsuneyama K; Takano Y
    Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):432-40. PubMed ID: 18091387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of N-myc downstream-regulated gene 1 in primary gallbladder carcinoma and its correlation with clinicopathological features and clinical outcome.
    Zhang SB; Song SP; Li B; Zhou YS; Zhang YD
    Med Oncol; 2012 Sep; 29(3):1866-72. PubMed ID: 21735144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Overexpression of NDRG1: relationship with proliferative activity and invasiveness of breast cancer cell line and breast cancer metastasis].
    Wang Z; Liu Q; Chen Q; Zhu R; Zhu HG
    Zhonghua Bing Li Xue Za Zhi; 2006 Jun; 35(6):333-8. PubMed ID: 16834906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Correlation of Skp2 expression in gastric carcinoma to expression of P27 and PTEN].
    Ma XM; Liu JH; Guo JW; Liu Y; Zuo LF
    Ai Zheng; 2006 Jan; 25(1):56-61. PubMed ID: 16405750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological significance of PTEN loss and the phosphoinositide 3-kinase/Akt pathway in sporadic colorectal neoplasms: is PTEN loss predictor of local recurrence?
    Colakoglu T; Yildirim S; Kayaselcuk F; Nursal TZ; Ezer A; Noyan T; Karakayali H; Haberal M
    Am J Surg; 2008 Jun; 195(6):719-25. PubMed ID: 18440486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognostic effect of PTEN expression status in colorectal cancer development and evaluation of factors affecting it: miR-21 and promoter methylation.
    Yazdani Y; Farazmandfar T; Azadeh H; Zekavatian Z
    J Biomed Sci; 2016 Jan; 23():9. PubMed ID: 26787105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulation of nemo-like kinase is an independent prognostic factor in colorectal cancer.
    Zhang W; He J; Du Y; Gao XH; Liu Y; Liu QZ; Chang WJ; Cao GW; Fu CG
    World J Gastroenterol; 2015 Aug; 21(29):8836-47. PubMed ID: 26269673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression and clinical significance of survivin gene and PTEN protein in colorectal adenocarcinoma].
    Yang D; Zhu YQ; Qi J
    Ai Zheng; 2004 Mar; 23(3):306-9. PubMed ID: 15025964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival stratification panel of colorectal carcinoma with combined expression of carcinoembryonic antigen, matrix metalloproteinases-2, and p27 kip1.
    Li M; Li JY; Zhao AL; He JS; Zhou LX; Li YA; Gu J
    Dis Colon Rectum; 2007 Nov; 50(11):1887-98. PubMed ID: 17882488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression of CD10 in cancer-associated fibroblasts and its effect on initiation and progression of colorectal carcinoma].
    Zhu Y; Zheng JJ; Yang F; Nie QQ; Zhu ZL; Deng H
    Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):859-865. PubMed ID: 28056302
    [No Abstract]   [Full Text] [Related]  

  • 39. Expression of valosin-containing protein in colorectal carcinomas as a predictor for disease recurrence and prognosis.
    Yamamoto S; Tomita Y; Hoshida Y; Sakon M; Kameyama M; Imaoka S; Sekimoto M; Nakamori S; Monden M; Aozasa K
    Clin Cancer Res; 2004 Jan; 10(2):651-7. PubMed ID: 14760088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NDRG1/Cap43/Drg-1 may predict tumor angiogenesis and poor outcome in patients with lung cancer.
    Azuma K; Kawahara A; Hattori S; Taira T; Tsurutani J; Watari K; Shibata T; Murakami Y; Takamori S; Ono M; Izumi H; Kage M; Yanagawa T; Nakagawa K; Hoshino T; Kuwano M
    J Thorac Oncol; 2012 May; 7(5):779-89. PubMed ID: 22481237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.